logo for Annexon Biosciences

Annexon Biosciences

Business Services · California, United States · 70 Employees

View Company Info for Free

About

Headquarters

1400 Sierra Point Pkwy Bldg C Ste 200, Brisbane...

Phone Number

(650) 822-5500

Revenue

$131.1 Million

Stock Symbol

ANNX

Industry

Business Services General Business Services

Highlights

$633.8M

Total Funding Amount

$130M

Most Recent Funding Amount

6

Number of Funding Rounds

Who is Annexon Biosciences

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated diso rders of the body, brain and eye. The company's pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. The company's first product candidate, ANX005, is a full-length monoclonal antibody formulated for intravenous administration in autoimmune and neurodegenerative disorders. The company's second product candidate, ANX007, is a monoclonal antibody Fab formulated for intravitreal administration for the treatment of neurodegenerative ophthalmic disorders. Based on learnings from its initial trials, Annexon is advancing its current programs while evaluating additional orphan and large market indications. Annexon is deploying a disciplined, biomarker-driven development strategy designed to establish confidence that each of its product candidates is engaging the specific target at a well-tolerated therapeutic dose in the intended patient tissue.Read more

Annexon Biosciences's Social MediaPopular SearchesAnnexon IncAnnexon BiosciencesAnnexonannexon LtdAnnexon Biosciences IncSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ANNXShow more

Annexon Biosciences Org Chart

PhoneEmail
Jamie Dananberg

Chief Medical Officer

PhoneEmail

PhoneEmail

PhoneEmail

Is Annexon Biosciences your ideal costumer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Similar Companies to Annexon Biosciences

Illustration of an envelope

Annexon Biosciences Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateJul 08, 2022
RoundShare Placement
Amount$130M
InvestorsRedmile Group, Adage Capital, Bain Capital, Driehaus Capital Management
Funding DateJul 24, 2020
RoundStock Issuance/Offering
Amount$250.8M
Investors
Funding DateJul 01, 2020
RoundUnspecified
Amount$100M
InvestorsFarallon Capital Management , L.L.C., Eventide Asset Management LLC, Logos Capital LLC, BlackRock , Inc., Surveyor Capital, Satter Medical Technology Partners, Redmile Group , LLC, The Blackstone Group L.P, New Enterprise Associates , Inc., Deerfield Communications Inc, ADAGE CAPITAL MANAGEMENT LP, Bain Capital LP, Janus Henderson Investors
See More

$633.8M

Total Funding Amount

$130M

Most Recent Funding Amount

6

Number of Funding Rounds

Annexon Biosciences Tech Stack

A closer look at the technologies used by Annexon Biosciences

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Most Recent Scoops

May 16 2024
Earnings
May 16 2024
Earnings
Financial Planning
May 16 2024
Earnings
Financial Planning
May 16 2024
Earnings
May 16 2024
Earnings
Financial Planning, Funding
See more scoops

Annexon Biosciences News & Media

Read more news

Frequently Asked Questions Regarding Annexon Biosciences

Where is Annexon Biosciences located?
Annexon Biosciences's headquarters are located at 1400 Sierra Point Pkwy Bldg C Ste 200, Brisbane, California, 94005, United States
What is Annexon Biosciences's phone number?
Annexon Biosciences's phone number is (650) 822-5500
What is Annexon Biosciences's stock symbol?
Annexon Biosciences's stock symbol is ANNX
What is Annexon Biosciences's official website?
Annexon Biosciences's official website is www.annexonbio.com
What is Annexon Biosciences's Revenue?
Annexon Biosciences's revenue is $131.1 Million
What is Annexon Biosciences's SIC code?
Annexon Biosciences's SIC: 28,283
What is Annexon Biosciences's NAICS code?
Annexon Biosciences's NAICS: 32,325
How many employees does Annexon Biosciences have?
Annexon Biosciences has 70 employees
What industry does Annexon Biosciences belong to?
Annexon Biosciences is in the industry of: Business Services General, Business Services
What is Annexon Biosciences competition?
Annexon Biosciences top competitors include: Checkmate Pharmaceuticals, Leap Therapeutics, GlycoMimetics, PROTAGONIST THERAPEUTICS
What technology does Annexon Biosciences use?
Some of the popular technologies that Annexon Biosciences uses are: Gupy, Zingfit, WordPress.org, Drupal
How do I contact Annexon Biosciences?
Annexon Biosciences contact info: Phone number: (650) 822-5500 Website: www.annexonbio.com
What does Annexon Biosciences do?

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company's pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, b... oth of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. The company's first product candidate, ANX005, is a full-length monoclonal antibody formulated for intravenous administration in autoimmune and neurodegenerative disorders. The company's second product candidate, ANX007, is a monoclonal antibody Fab formulated for intravitreal administration for the treatment of neurodegenerative ophthalmic disorders. Based on learnings from its initial trials, Annexon is advancing its current programs while evaluating additional orphan and large market indications. Annexon is deploying a disciplined, biomarker-driven development strategy designed to establish confidence that each of its product candidates is engaging the specific target at a well-tolerated therapeutic dose in the intended patient tissue.Read More

What are Annexon Biosciences social media links?
Annexon Biosciences Linkedin page Annexon Biosciences Twitter page Annexon Biosciences Facebook page
How much funding has Annexon Biosciences raised to date?
Annexon Biosciences has raised $633.8 Million in 6 funding rounds
When was the last funding round for Annexon Biosciences?
Annexon Biosciences closed its last funding round on Jul 08, 2022 with the amount of $130 Million
Who invested in Annexon Biosciences?
Annexon Biosciences has 25 investors including Novartis Venture Fund, Correlation Ventures, Novartis, Clarus Ventures and LLC.
Is Annexon Biosciences a public company?
Yes, Annexon Biosciences is a public company and is traded under the symbol ANNX
See more information about Annexon Biosciences

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.